Acumen Research and Consulting estimates that global Drug Delivery Devices market is expected to reach the market value of around US$ 2.8 Bn by 2027 and is anticipated to grow at a CAGR of around 6.2% in terms of revenue during the forecast period 2020 – 2027.
Drug delivery devices are the medical devices used to dispose of drugs into human bodies and systems. They are specially designed to dispatch specific drugs in accordance with different techniques of administration. These devices are used for therapeutic and recovery therapies.
The report provides analysis of global Drug Delivery Devices market for the period 2016-2027, wherein 2020 to 2027 is the forecast period and 2019 is considered as the base year.
Market Insights
Increase the budget for drug discovery, growing consumer demand for drug delivery devices and expanded policy support for research and development, push the global market for drug delivery devices. In addition, the market for medicines is expected to be driven by an increase in prevalence of diabetic medicines, leading to hyperglycemia. In order to promote autonomy of patients, it is predicted that the demand will expand in the near future with an increase in the number of patients who favor the use of modern medication delivery systems. In the next few years the market of drugs delivery devices is expected to be restrained by high research and development and equipment costs, high maintenance costs and introduction of alternative therapy in developed countries.
Regional Stance
North America held significant market share due to growing use of medications in health care facilities, availability and accessibility of reimbursements for the majority of the population, increasing prevails of chronic disease (diabetes and cancer), increasing geriatric population, rising awareness of drug metabolism, and increased patient preference, Other factors that are driving market growth include innovation and the development of drug delivery solutions, technology developments, new and innovative product launches and pain reduction.
Besides, the production of innovative drug supply solutions is likely to be a predominant trend in the market. The non-invasive drug delivery mode is now ready to compete in conventional oral and injection pathways through medical device progress and certain methods of transdermal delivery. The adherence of patients by non-invasive interventions was shown to be slightly higher due to reduced medication-related pain and thus these strategies were viewed as preferring drugs. Owing to the increasing growth and advancement on the market as well as the use of injectable medication delivery methods, medical device firms will also benefit greatly from the introduction of new advanced devices.
Report coverage
The market research study on “Drug Delivery Devices Market (Drug Delivery Devices Market By Route of Administration: Inhalation, Topical, Injection, Transmucosal; Drug Delivery Devices Market By Patient Care Setting: Diagnostic Centers, Home Care Settings, Hospitals, Ambulatory Surgery Centers, Others; Drug Delivery Devices Market By Application: Infectious Diseases, Cancer, Respiratory Diseases, Cardiovascular Diseases, Central Nervous System Disorders, Diabetes, Autoimmune Diseases, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2020 - 2027) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2020 - 2027” offers a detailed insights on the global Drug Delivery Devices market entailing insights on its different market segments. Market dynamics with drivers, restraints and opportunities with their impact are provided in the report. The report also provides competitive landscape to understand the current stance of particular player. The report covers global Drug Delivery Devices market size, and segment markets by type, application, and geography along with the information on companies operating in the market. The Drug Delivery Devices market analysis is provided for major regional markets including North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. For each region, the market size for different segments has been covered under the scope of report.
The global Drug Delivery Devices market is segmented as below:
Market Segmentation
Drug Delivery Devices Market By Route of Administration
Inhalation
Topical
Injection
Transmucosal
Drug Delivery Devices Market By Patient Care Setting
Diagnostic Centers
Home Care Settings
Hospitals
Ambulatory Surgery Centers/Clinics
Others
Drug Delivery Devices Market By Application
Infectious Diseases
Cancer
Respiratory Diseases
Cardiovascular Diseases
Central Nervous System Disorders
Diabetes
Autoimmune Diseases
Others
Drug Delivery Devices Market By Geography
North America
Europe
- UK
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of MEA
Key Players and Market Situation
Participants include major global players such B. Braun Melsungen AG, 3M, Abbott Laboratories, Pfizer, Inc., Baxter International Inc., Smith Medical, F. Hoffmann-La Roche Ltd., CareFusion Corporation, and Others.
2018, Gerresheimer AG has announced that it has purchased Sensile Medical and with this transaction has increased its business portfolios. Owing to Sensile's experience in the design and usage of liquid drug delivery systems, this purchase would serve to broaden the technical range of Gerresheimer AG.
Table Of Content:
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Drug Delivery Devices
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Drug Delivery Devices Market By Route of Administration
1.2.2.1. Global Drug Delivery Devices Market Revenue and Growth Rate Comparison By Route of Administration(2020-2027)
1.2.2.2. Global Drug Delivery Devices Market Revenue Share By Route of Administration in 2019
1.2.2.3. Inhalation
1.2.2.4. Topical
1.2.2.5. Injection
1.2.2.6. Transmucosal
1.2.3. Drug Delivery Devices Market By Patient Care Setting
1.2.3.1. Global Drug Delivery Devices Market Revenue and Growth Rate Comparison By Patient Care Setting (2020-2027)
1.2.3.2. Global Drug Delivery Devices Market Revenue Share By Patient Care Setting in 2019
1.2.3.2.1. Diagnostic Centers
1.2.3.2.2. Home Care Settings
1.2.3.2.3. Hospitals
1.2.3.2.4. Ambulatory Surgery Centers/Clinics
1.2.3.2.5. Others
1.2.4. Drug Delivery Devices Market By Application
1.2.4.1. Global Drug Delivery Devices Market Revenue and Growth Rate Comparison By Application(2020-2027)
1.2.4.2. Global Drug Delivery Devices Market Revenue Share By Application in 2019
1.2.4.2.1. Infectious Diseases
1.2.4.2.2. Cancer
1.2.4.2.3. Respiratory Diseases
1.2.4.2.4. Cardiovascular Diseases
1.2.4.2.5. Central Nervous System Disorders
1.2.4.2.6. Diabetes
1.2.4.2.7. Autoimmune Diseases
1.2.4.2.8. Others
1.2.5. Drug Delivery Devices Market By Geography
1.2.5.1. Global Drug Delivery Devices Market Revenue and Growth Rate Comparison by Geography (2020-2027)
1.2.5.2. North America Drug Delivery Devices Market Revenue and Growth Rate(2020-2027)
1.2.5.3. Europe Drug Delivery Devices Market Revenue and Growth Rate(2020-2027)
1.2.5.4. Asia-Pacific Drug Delivery Devices Market Revenue and Growth Rate(2020-2027)
1.2.5.5. Latin America Drug Delivery Devices Market Revenue and Growth Rate(2020-2027)
1.2.5.6. Middle East and Africa (MEA) Drug Delivery Devices Market Revenue and Growth Rate(2020-2027)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2019
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING Drug Delivery Devices ANALYSIS
3.1. Capacity and Commercial Production Date of Global Drug Delivery Devices Major Manufacturers in 2019
3.2. Manufacturing Plants Distribution of Global Drug Delivery Devices Major Manufacturers in 2019
3.3. R&D Status and Manufacturing End-User of Global Drug Delivery Devices Major Manufacturers in 2019
3.4. Raw Materials End-Users Analysis of Global Drug Delivery Devices Major Manufacturers in 2019
CHAPTER 4. Drug Delivery Devices MARKET By Route of Administration
4.1. Global Drug Delivery Devices Revenue By Route of Administration
4.2. Inhalation
4.2.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
4.3. Topical
4.3.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
4.4. Injection
4.4.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
4.5. Transmucosal
4.5.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
CHAPTER 5. Drug Delivery Devices MARKET By Patient Care Setting
5.1. Global Drug Delivery Devices Revenue By Patient Care Setting
5.2. Diagnostic Centers
5.2.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
5.3. Home Care Settings
5.3.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
5.4. Hospitals
5.4.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
5.5. Ambulatory Surgery Centers/Clinics
5.5.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
5.6. Others
5.6.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
5.6.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
CHAPTER 6. Drug Delivery Devices MARKET By Application
6.1. Global Drug Delivery Devices Revenue By Application
6.2. Infectious Diseases
6.2.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
6.3. Cancer
6.3.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
6.4. Respiratory Diseases
6.4.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
6.5. Cardiovascular Diseases
6.5.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
6.6. Central Nervous System Disorders
6.6.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
6.6.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
6.7. Diabetes
6.7.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
6.7.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
6.8. Autoimmune Diseases
6.8.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
6.8.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
6.9. Others
6.9.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
6.9.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
CHAPTER 7. NORTH AMERICA Drug Delivery Devices MARKET BY COUNTRY
7.1. North America Drug Delivery Devices Market Revenue and Growth Rate, 2020 - 2027 ($Million)
7.2. North America Drug Delivery Devices Market Revenue Share Comparison, 2020 & 2027 (%)
7.3. U.S.
7.3.1. U.S. Drug Delivery Devices Market Revenue and Forecast By Route of Administration, 2020 - 2027 ($Million)
7.3.2. Market Revenue and Forecast By Patient Care Setting, 2020 - 2027 ($Million)
7.3.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Route of Administration, 2020 - 2027 ($Million)
7.4.2. Market Revenue and Forecast By Patient Care Setting, 2020 - 2027 ($Million)
7.4.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
CHAPTER 8. EUROPE SMART REFRIGERATOR MARKET BY COUNTRY
8.1. Europe Drug Delivery Devices Market Revenue and Growth Rate, 2020 - 2027 ($Million)
8.2. Europe Drug Delivery Devices Market Revenue Share Comparison, 2020 & 2027 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Route of Administration, 2020 - 2027 ($Million)
8.3.2. Market Revenue and Forecast By Patient Care Setting, 2020 - 2027 ($Million)
8.3.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Route of Administration, 2020 - 2027 ($Million)
8.4.2. Market Revenue and Forecast By Patient Care Setting, 2020 - 2027 ($Million)
8.4.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Route of Administration, 2020 - 2027 ($Million)
8.5.2. Market Revenue and Forecast By Patient Care Setting, 2020 - 2027 ($Million)
8.5.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Route of Administration, 2020 - 2027 ($Million)
8.6.2. Market Revenue and Forecast By Patient Care Setting, 2020 - 2027 ($Million)
8.6.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Route of Administration, 2020 - 2027 ($Million)
8.7.2. Market Revenue and Forecast By Patient Care Setting, 2020 - 2027 ($Million)
8.7.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
CHAPTER 9. ASIA-PACIFIC Drug Delivery Devices MARKET BY COUNTRY
9.1. Asia-Pacific Drug Delivery Devices Market Revenue and Growth Rate, 2020 - 2027 ($Million)
9.2. Asia-Pacific Drug Delivery Devices Market Revenue Share Comparison, 2020 & 2027 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Route of Administration, 2020 - 2027 ($Million)
9.3.2. Market Revenue and Forecast By Patient Care Setting, 2020 - 2027 ($Million)
9.3.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Route of Administration, 2020 - 2027 ($Million)
9.4.2. Market Revenue and Forecast By Patient Care Setting, 2020 - 2027 ($Million)
9.4.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Route of Administration, 2020 - 2027 ($Million)
9.5.2. Market Revenue and Forecast By Patient Care Setting, 2020 - 2027 ($Million)
9.5.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Route of Administration, 2020 - 2027 ($Million)
9.6.2. Market Revenue and Forecast By Patient Care Setting, 2020 - 2027 ($Million)
9.6.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Route of Administration, 2020 - 2027 ($Million)
9.7.2. Market Revenue and Forecast By Patient Care Setting, 2020 - 2027 ($Million)
9.7.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Route of Administration, 2020 - 2027 ($Million)
9.8.2. Market Revenue and Forecast By Patient Care Setting, 2020 - 2027 ($Million)
9.8.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
CHAPTER 10. LATIN AMERICA Drug Delivery Devices MARKET BY COUNTRY
10.1. Latin America Drug Delivery Devices Market Revenue and Growth Rate, 2020 - 2027 ($Million)
10.2. Latin America Drug Delivery Devices Market Revenue Share Comparison, 2020 & 2027 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Route of Administration, 2020 - 2027 ($Million)
10.3.2. Market Revenue and Forecast By Patient Care Setting, 2020 - 2027 ($Million)
10.3.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
10.4. Mexico
10.4.1. Market Revenue and Forecast By Route of Administration, 2020 - 2027 ($Million)
10.4.2. Market Revenue and Forecast By Patient Care Setting, 2020 - 2027 ($Million)
10.4.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Route of Administration, 2020 - 2027 ($Million)
10.5.2. Market Revenue and Forecast By Patient Care Setting, 2020 - 2027 ($Million)
10.5.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
CHAPTER 11. MIDDLE EAST & AFRICA Drug Delivery Devices MARKET BY COUNTRY
11.1. Middle East & Africa Drug Delivery Devices Market Revenue and Growth Rate, 2020 - 2027 ($Million)
11.2. Middle East & Africa Drug Delivery Devices Market Revenue Share Comparison, 2020 & 2027 (%)
11.3. GCC
11.3.1. Market Revenue and Forecast By Route of Administration, 2020 - 2027 ($Million)
11.3.2. Market Revenue and Forecast By Patient Care Setting, 2020 - 2027 ($Million)
11.3.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
11.4. South Africa
11.4.1. Market Revenue and Forecast By Route of Administration, 2020 - 2027 ($Million)
11.4.2. Market Revenue and Forecast By Patient Care Setting, 2020 - 2027 ($Million)
11.4.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
11.5. Rest of Middle East & Africa
11.5.1. Market Revenue and Forecast By Route of Administration, 2020 - 2027 ($Million)
11.5.2. Market Revenue and Forecast By Patient Care Setting, 2020 - 2027 ($Million)
11.5.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
CHAPTER 12. COMPANY PROFILE
12.1. B. Braun Melsungen AG
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. 3M
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Abbott Laboratories
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Pfizer, Inc.
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Baxter International Inc.
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. Smith Medical
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. F. Hoffmann-La Roche Ltd.
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. CareFusion Corporation
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. Others
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. Key Developments
12.9.6. Strategies
CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope
